A recent study reveals that patients who stop using new slimming jabs like semaglutide or tirzepatide tend to recover lost weight at a significantly accelerated pace than those who halt traditional lifestyle plans.
Research printed in a major health publication points out that while obese people can lose substantial amounts of their body weight while on the medication, the mass comes back at an average rate of nearly a kilo each month once they quit.
"People buying these medications should be informed of the risk of rapid weight regain when the medication is stopped," stated lead investigator Dr. Susan Jebb.
That rate of recovery means a return to starting mass within about one and a half years.
Analyzing Therapies
The study, which looked at dozens of studies involving thousands of participants, compared the outcomes of GLP-1 agonists with other pills.
Researchers note that individuals who shed pounds through lifestyle changes alone usually experience a slower creep back—perhaps 0.1 kg a month—post-intervention.
Understanding the Quick Rebound
Experts propose the mechanism of the injections explains the amplified weight return.
The injections imitate a natural hormone called GLP-1, which controls feelings of fullness.
"Artificially providing the hormone concentrations several times higher than normal might result in the system to produce less of its own natural hormone, and could diminish responsiveness to its effects," noted Dr. Adam Collins, a dietetics researcher.
"Withdrawal of this GLP-1 'fix' means hunger is no longer kept in check, making overeating far more likely."
A Lifelong Condition?
The NHS advise the jabs for individuals with weight-linked medical conditions, accompanied by prescribed lifestyle changes.
A number of clinicians contend that, considering the high risk of weight regain, the therapy might need to be life-long.
This perspective is echoed by drug manufacturers, who state that the results "emphasize the chronic nature of excess weight," similar to managing diseases like high blood pressure.
Patient Testimonies
Users who have come off the jabs describe a powerful resurgence of cravings.
"It felt as if something activating and you're instantly starving," described a patient.
The struggle is compounded if users have not adopted lasting lifestyle or habit changes during treatment.
Significant Use
Figures show that millions of adults in the UK have tried these injections in the last 12 months, with desire being substantial.
- Use is higher among females than men.
- The 40s and 50s demographic shows the greatest usage rates.
- A large proportion access the drugs through private prescriptions rather than public health services.
In conclusion, researchers caution that while the jabs are powerful agents for weight loss, they are not a permanent fix and maintained weight loss relies on combined lifestyle management.
